Evidence map›Paper›PMID 23690308›Full record

ArticleThe Journal of clinical endocrinology and metabolism2013

Modifiers of ovarian function in girls and women with classic galactosemia.

Jessica B Spencer, Jennifer R Badik, Emily L Ryan, Tyler J Gleason, K Alaine Broadaway, Michael P Epstein, Judith L Fridovich-Keil

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Reproductive potential in classical galactosemia: A case series based perspective.European journal of obstetrics & gynecology and reproductive biology: X · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Current and Future Treatments for Classic Galactosemia.Journal of personalized medicine · 2021
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jessica B SpencerDivision of Reproductive Endocrinology and Infertility, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Jennifer R Badik
Emily L Ryan
Tyler J Gleason
K Alaine Broadaway
Michael P Epstein
Judith L Fridovich-Keil
Emory University · USDiabetes Australia · AU

Funding

Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
Training Program in Biochemistry, Cell and Molecular BiologyT32GM008367 · NIGMS · EMORY UNIVERSITY · PI BOISE, LAWRENCE H., CORBETT, ANITA H. · 1990 to 2019
$5.6M
Studies of Galactose Toxicity in Yeast and Human CellsR01DK059904 · NIDDK · EMORY UNIVERSITY · PI FRIDOVICH-KEIL, JUDITH L. · 2002 to 2011
$3.2M
ENDOCRINOLOGY, METABOLISM, AND DIABETEST32DK007298 · NIDDK · EMORY UNIVERSITY · PI PACIFICI, ROBERTO · 1986 to 2014
$3.2M
HUMAN ENZYMES UNDERLYING GALACTOSEMIAR01DK046403 · NIDDK · EMORY UNIVERSITY · PI FRIDOVICH-KEIL, JUDITH L. · 1998 to 2011
$3.0M
Training Program in Human Disease GeneticsT32MH087977 · NIMH · EMORY UNIVERSITY · PI WARREN, STEPHEN T. · 2009 to 2013
$1.3M
Atlanta Clinical and Translational Science Institute (ACTSI) RenewalTL1TR000456 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$1.2M
Atlanta Clinical and Translational Science Institute (TL1)TL1RR025010 · NCRR · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2007 to 2011
$1.1M
NCATS NIH HHS TL1 TR000456NCATS NIH HHS UL1 TR000454NCRR NIH HHS TL1 RR025010NIDDK NIH HHS R01 DK046403NIDDK NIH HHS R01 DK059904NIDDK NIH HHS T32 DK007298NIDDK NIH HHS T32 DK007298-31NIGMS NIH HHS T32 GM008367NIMH NIH HHS T32 MH087977
6 · The paper itself

Abstract

contextClassic galactosemia is a potentially lethal genetic disorder resulting from profound impairment of galactose-1P uridylyltransferase (GALT). More than 80% of girls and women with classic galactosemia experience primary or premature ovarian insufficiency despite neonatal diagnosis and rigorous lifelong dietary galactose restriction.

objectiveThe goal of this study was to test the relationship between markers of ovarian reserve, cryptic residual GALT activity, and spontaneous pubertal development in girls with classic galactosemia. DESIGN AND

settingThis was a cross-sectional study with some longitudinal follow-up in a university research environment. PATIENTS: Patients included girls and women with classic galactosemia and unaffected controls, <1 month to 30 years old.

main outcome measuresWe evaluated plasma anti-Müllerian hormone (AMH) and FSH levels, antral follicle counts ascertained by ultrasound, and ovarian function as indicated by spontaneous vs assisted menarche.

resultsMore than 73% of the pre- and postpubertal girls and women with classic galactosemia in this study, ages >3 months to 30 years, demonstrated AMH levels below the 95% confidence interval for AMH among controls of the same age, and both pre- and postpubertal girls and women with classic galactosemia also demonstrated abnormally low antral follicle counts relative to age-matched controls. Predicted residual GALT activity ≥ 0.4% significantly increased the likelihood that a girl with classic galactosemia would demonstrate an AMH level ≥ 0.1 ng/mL.

conclusionsA majority of girls with classic galactosemia demonstrate evidence of diminished ovarian reserve by 3 months of age, and predicted cryptic residual GALT activity is a modifier of ovarian function in galactosemic girls and women.

Indexed as

Down-RegulationAdolescentAdultAnti-Mullerian HormoneBiomarkersChildChild, PreschoolCross-Sectional StudiesFemaleFollow-Up StudiesGalactosemiasHumansInfantInfant, NewbornLongitudinal StudiesMutant ProteinsAnti-Mullerian HormoneBiomarkersMutant ProteinsRecombinant ProteinsUTP-Hexose-1-Phosphate Uridylyltransferase

Identifiers

PMID23690308
PMCPMC3701263
OpenAlexW2040109827

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.